Immunome (IMNM) Operating Margin (2023 - 2025)
Immunome's (IMNM) quarterly Operating Margin came in at 1157.61% in Q2 2025, up 53482.0% YoY from N/an in Q2 2024, and up 24.12% on a QoQ basis from 1525.5% in Q1 2025.
Powered by 
Analysis
Immunome (IMNM) Operating Margin (2023 - 2025) Analysis & Trends
Immunome (IMNM) has 3 years of Operating Margin data on file, last reported at 1157.61% in Q2 2025.
- Quarterly Operating Margin rose 53482.0% year-over-year to 1157.61% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 5947.9% (down 395359.0% YoY) and the FY2025 annual result came in at 3228.83%, up 15354.0% from the prior year.
- Operating Margin advanced to 1157.61% in Q2 2025, from 1525.5% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 129.96% in Q3 2023 to a low of 12857.05% in Q1 2024.
- A 3-year average of 2492.75% and a median of 1608.96% in 2025 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2024 — Operating Margin plunged 1266792 bps — and 2025, when it surged 1133155 bps.
- Tracing IMNM's Operating Margin over 3 years: stood at 2473.94% in 2023, then decreased by 22 bps to 3030.31% in 2024, then soared by 62 bps to 1157.61% in 2025.
- The last three Operating Margin figures came in at 1157.61% (Q2 2025), 1525.5% (Q1 2025), and 3030.31% (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Immunome | 3.03 Bn | 2.51 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1,157.61% |
| Mar 31, 2025 | -1,525.50% |
| Dec 31, 2024 | -3,030.31% |
| Sep 30, 2024 | -1,736.15% |
| Jun 30, 2024 | -1,692.43% |
| Mar 31, 2024 | -12,857.05% |
| Dec 31, 2023 | -2,473.94% |
| Sep 30, 2023 | -129.96% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -189.13% |